These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16316485)

  • 1. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine.
    Savaskan E; Schnitzler C; Schröder C; Cajochen C; Müller-Spahn F; Wirz-Justice A
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):507-16. PubMed ID: 16316485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cognitive function improve with quetiapine in comparison to haloperidol?
    Velligan DI; Newcomer J; Pultz J; Csernansky J; Hoff AL; Mahurin R; Miller AL
    Schizophr Res; 2002 Jan; 53(3):239-48. PubMed ID: 11738537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    Purdon SE; Malla A; Labelle A; Lit W
    J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
    Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial.
    Maneeton B; Maneeton N; Srisurapanont M; Chittawatanarat K
    Drug Des Devel Ther; 2013; 7():657-67. PubMed ID: 23926422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
    Buckley PF; Goldstein JM; Emsley RA
    Schizophr Res; 2004 Feb; 66(2-3):143-50. PubMed ID: 15061246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):175-82. PubMed ID: 15737251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
    Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
    Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of delirium in older adults with quetiapine.
    Kim KY; Bader GM; Kotlyar V; Gropper D
    J Geriatr Psychiatry Neurol; 2003 Mar; 16(1):29-31. PubMed ID: 12641370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
    McIntyre RS; Brecher M; Paulsson B; Huizar K; Mullen J
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):573-85. PubMed ID: 16139175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
    Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?
    Farina E; Mantovani F; Fioravanti R; Pignatti R; Chiavari L; Imbornone E; Olivotto F; Alberoni M; Mariani C; Nemni R
    Aging Ment Health; 2006 May; 10(3):211-8. PubMed ID: 16777648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP; Eriksson H; Svensson H;
    Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease.
    D'Onofrio G; Sancarlo D; Addante F; Ciccone F; Cascavilla L; Paris F; Elia AC; Nuzzaci C; Picoco M; Greco A; Panza F; Pilotto A
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):965-75. PubMed ID: 25504466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of nifedipine on the effectiveness of antipsychotic therapy in schizophrenia].
    Dzhuga NP; Kozlovskiĭ VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):32-5. PubMed ID: 19738566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
    Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.